Brief: Beam Therapeutics Q3 EPS USD -1.22
08/11/2023 11:31
Nov 8 (Reuters) - Beam Therapeutics Q3 pretax profit USD -96.088 million. * Q3 operating expenses USD 125.46 million * Q3 net income USD -96.088 million * Q3 operating income USD -108.267 million * Q3 EPS USD -1.22
Recent news on Beam Therapeutics
See all newsBeam Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Beam Therapeutics Q1 net loss narrows beating analyst estimates
U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings
U.S. STOCKS ON THE MOVE-BWX, Generac, Cintas
U.S. STOCKS ON THE MOVE-Arm, On Holding, Sarepta